| PHIO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PHIO Shares Outstanding History and PHIO YTD Return |

| PHIO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: PHIO Shares Outstanding History and PHIO YTD Return |
| PHIO Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+11.93% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHIO Stock Price Chart |
| About Phio Pharmaceuticals Corp |
| Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. Co.'s INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. It is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. Co.'s pipeline is focused on the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma. Its product pipeline includes PH-762 and PH-894. PH-762 is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). We show 29 historical shares outstanding datapoints in our PHIO shares outstanding history coverage, used to compute PHIO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PHIO market cap history over the course of time is important for investors interested in comparing PHIO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PHIO versus a peer is one thing; comparing PHIO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PHIO can fluctuate over the course of history. With this page we aim to empower investors researching PHIO by allowing them to research the PHIO market cap history. |
| PHIO Current Stock Quote |
Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| PHIO Share Performance |
| Market Cap Peers |
| Phio Pharmaceuticals (PHIO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
PIII Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.6%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.6%.